Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RV7J
|
|||
| Former ID |
DIB014987
|
|||
| Drug Name |
RG-7256
|
|||
| Synonyms |
B-raf inhibitor (melanoma), Roche/Plexxikon
Click to Show/Hide
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Discontinued in Phase 1 | [1] | |
| Company |
Roche Holding AG
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022593) | |||
| REF 2 | First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors. Target Oncol. 2016 Apr;11(2):149-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.